title: Cytokines as therapeutic targets: advances and limitations.
abstract: Biological therapies targeting cytokines, T cells, or B cells have improved outcomes of inflammatory diseases. However, many issues remain open: What is the best target? How well can response be predicted? How can cure be achieved?
authors.affiliation: Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
authors.forename: Clemens
authors.initials: C
authors.lastname: Scheinecker
authors.forename: Kurt
authors.initials: K
authors.lastname: Redlich
authors.forename: Josef S
authors.initials: JS
authors.lastname: Smolen
mesh_terms: D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D016207:Cytokines / Q000037:antagonists & inhibitors* / Q000502:physiology*; D016503:Drug Delivery Systems / Q000009:adverse effects / Q000379:methods* / Q000639:trends*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology*; D016032:Randomized Controlled Trials as Topic
chemical_list: D016207:Cytokines